SCHEMBL19903094

SCHEMBL19903094

C=C(NC)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.46
▸ TACR1 P25103 4/20 0.38
▸ CES2 O00748 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ TACR3 P29371 2/20 0.35
▸ RAPGEF4 Q8WZA2 1/20 0.34
▸ HDAC3 O15379 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ AR P10275 1/20 0.33
▸ XPO1 O14980 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ P2RX1 P51575 1/20 0.32
▸ NOTUM Q6P988 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ GPR35 Q9HC97 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5788966 0.76 MAPT (0.55) MAPTTACR1CES2ALDH1A1TACR3
SCHEMBL25460884 0.71 MAPT (0.49) MAPTTACR1CES2ALDH1A1TACR3
SCHEMBL4028192 0.68 APP (0.53) MAPTTACR1CES2ALDH1A1LMNA
SCHEMBL4030734 0.68 CES2 (0.47) MAPTTACR1CES2ALDH1A1HDAC3
SCHEMBL4251643 0.67 MAPT (0.44) MAPTTACR1CES2ALDH1A1RAPGEF4
SCHEMBL1202442 0.67 CES2 (0.50) MAPTTACR1CES2ALDH1A1TACR3
Hydrochloric Acid SCHEMBL5756823 0.67 APP (0.51) MAPTTACR1CES2ALDH1A1LMNA
SCHEMBL440959 0.66 CES2 (0.58) MAPTCES2ALDH1A1RAPGEF4XPO1
SCHEMBL7216715 0.66 CES2 (0.48) MAPTCES2RAPGEF4ARXPO1
SCHEMBL4564009 0.66 CES2 (0.48) MAPTCES2RAPGEF4ARXPO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3067349-B1 CARBOXYMETHYL PIPERIDINE DERIVATIVE KISSEI PHARMACEUTICAL (JP) 2018-02-28 — — EP disclosed
Send feedback